KYNB CIK: 921299

Kyntra Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−82.2
FY22:
−146
FY23:
−315
FY24:
−138
FY25:
−4.77
Change from FY21 to FY25
millions USD
FY21:
−427
FY22:
89.1
FY23:
154
FY24:
126
FY25:
35.4
Change from FY21 to FY25
millions USD
FY21:
−0.56
FY22:
46.8
FY23:
123
FY24:
−0.26
FY25:
−86.0
millions USD
FY21:
−507
FY22:
−15.5
FY23:
−42.0
FY24:
−11.5
FY25:
−54.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−87.4
FY22:
−150
FY23:
−318
FY24:
−138
FY25:
−4.81

All amounts in millions USD Data source:SEC EDGAR